Cargando…
Correction to: Vestronidase Alfa: A Review in Mucopolysaccharidosis VII
Autores principales: | McCafferty, Emma H., Scott, Lesley J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533409/ https://www.ncbi.nlm.nih.gov/pubmed/30993593 http://dx.doi.org/10.1007/s40259-019-00353-6 |
Ejemplares similares
-
Vestronidase Alfa: A Review in Mucopolysaccharidosis VII
por: McCafferty, Emma H., et al.
Publicado: (2019) -
Open-label phase 1/2 study of vestronidase alfa for mucopolysaccharidosis VII
por: Jones, Simon, et al.
Publicado: (2021) -
Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study population
por: Haller, Christine, et al.
Publicado: (2019) -
Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials
por: Qi, Yulan, et al.
Publicado: (2018) -
Correction to: Migalastat: A Review in Fabry Disease
por: McCafferty, Emma H., et al.
Publicado: (2019)